4//SEC Filing
Elsbree David B 4
Accession 0000899243-21-026528
CIK 0001492674other
Filed
Jun 28, 8:00 PM ET
Accepted
Jun 29, 2:56 PM ET
Size
10.3 KB
Accession
0000899243-21-026528
Insider Transaction Report
Form 4
Elsbree David B
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2021-06-25−45,454→ 45,454 total→ Common Stock (45,454 underlying) - Exercise/Conversion
Common Stock
2021-06-25+45,454→ 170,723 total - Award
Restricted Stock Units
2021-06-25+73,224→ 73,224 total→ Common Stock (73,224 underlying)
Holdings
- 10,000(indirect: By Spouse)
Common Stock
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
- [F2]The reporting person disclaims ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- [F3]On August 6, 2020 the reporting person was granted 45,454 restricted stock units that vested on June 25, 2021.
- [F4]The restricted stock units vest in one installment on the earlier of (i) June 25, 2022 and (ii) the date of the next annual meeting of stockholders.
Documents
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeother
Related Parties
1- filerCIK 0001292650
Filing Metadata
- Form type
- 4
- Filed
- Jun 28, 8:00 PM ET
- Accepted
- Jun 29, 2:56 PM ET
- Size
- 10.3 KB